Doheny Eye Institute

Fresh Perspectives on Retinopathy Retinopathy remains the leading cause of vision loss in the global working population. Regardless of whether it is triggered by ischemia or diabetes, the late vision-threatening stage of retinopathy is marked by VEGF-mediated pathological neovascularization and concomitant vascular leakage. As such, anti-VEGF therapies have long been the preferred strategy to manage […]